DOCK2 Promotes Pleural Fibrosis by Modulating Mesothelial to Mesenchymal Transition
Authors:
- 1 February 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Respiratory Cell and Molecular Biology
- Vol. 66 (2) , 171-182
Abstract
Mesothelial to mesenchymal transition (MesoMT) is one of the crucial mechanisms underlying pleural fibrosis, which results in restrictive lung disease. DOCK2 (dedicator of cytokinesis 2) plays important roles in immune functions; however, its role in pleural fibrosis, particularly MesoMT, remains unknown. We found that amounts of DOCK2 and the MesoMT marker α-SMA (α-smooth muscle actin) were significantly elevated and colocalized in the thickened pleura of patients with nonspecific pleuritis, suggesting the involvement of DOCK2 in the pathogenesis of MesoMT and pleural fibrosis. Likewise, data from three different pleural fibrosis models (TGF-β [transforming growth factor-β], carbon black/bleomycin, and streptococcal empyema) consistently demonstrated DOCK2 upregulation and its colocalization with α-SMA in the pleura. In addition, induced DOCK2 colocalized with the mesothelial marker calretinin, implicating DOCK2 in the regulation of MesoMT. Our in vivo data also showed that DOCK2-knockout mice were protected from Streptococcus pneumoniae–induced pleural fibrosis, impaired lung compliance, and collagen deposition. To determine the involvement of DOCK2 in MesoMT, we treated primary human pleural mesothelial cells with the potent MesoMT inducer TGF-β. TGF-β significantly induced DOCK2 expression in a time-dependent manner, together with α-SMA, collagen 1, and fibronectin. Furthermore, DOCK2 knockdown significantly attenuated TGF-β–induced α-SMA, collagen 1, and fibronectin expression, suggesting the importance of DOCK2 in TGF-β–induced MesoMT. DOCK2 knockdown also inhibited TGF-β–induced Snail upregulation, which may account for its role in regulating MesoMT. Taken together, the current study provides evidence that DOCK2 contributes to the pathogenesis of pleural fibrosis by mediating MesoMT and deposition of neomatrix and may represent a novel target for its prevention or treatment.Keywords
Funding Information
- Foundation for the National Institutes of Health (HL130133)
- Foundation for the National Institutes of Health (HL141583)
- Foundation for the National Institutes of Health (HL142853)
- Foundation for the National Institutes of Health (HL130133)
- Foundation for the National Institutes of Health (HL141583)
- Foundation for the National Institutes of Health (HL142853)
This publication has 45 references indexed in Scilit:
- Plasminogen Activator Inhibitor-1 Deficiency Augments Visceral Mesothelial Organization, Intrapleural Coagulation, and Lung Restriction in Mice with Carbon Black/Bleomycin–Induced Pleural InjuryAmerican Journal of Respiratory Cell and Molecular Biology, 2014
- Pleural Mesothelial Cell Differentiation and Invasion in Fibrogenic Lung InjuryThe American Journal of Pathology, 2013
- Structural basis for mutual relief of the Rac guanine nucleotide exchange factor DOCK2 and its partner ELMO1 from their autoinhibited formsProceedings of the National Academy of Sciences, 2012
- Deconstructing the mechanisms and consequences of TGF-β-induced EMT during cancer progressionCell and tissue research, 2011
- Response gene to complement 32 interacts with Smad3 to promote epithelial-mesenchymal transition of human renal tubular cellsAmerican Journal of Physiology-Cell Physiology, 2011
- Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injuryJournal of Clinical Investigation, 2009
- Pleural mesothelial cell transformation into myofibroblasts and haptotactic migration in response to TGF-β1 in vitroAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2009
- Pathogenesis of pleural fibrosisRespirology, 2004
- Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migrationNature, 2001
- CalretininActa Cytologica, 1997